fNIRS-based Neurofeedback Intervention for Cognitive Control Improvement in Emotional Overeating

NCT ID: NCT05200182

Last Updated: 2024-04-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

80 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-04-07

Study Completion Date

2025-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Emotional overeating is characterized by an excessive food intake in the context of intense emotional situations, such as acute stress one. Emotional overeating, as a behavioral trait, can increase the risk of to develop eating disorders or eating-related diseases, such as metabolic syndrome, obesity, type-2 diabetes. Recently, imaging modalities, such as magnetic resonance imaging (MRI) and electro-encephalography (EEG), have been adapted in order to perform neurofeedback consisting on presenting the brain activity instantaneously to the participant, that give him the possibility to modify this activity by his own mean. Neurofeedback has already shown some efficacy, either with explicit or implicit instruction.

Compared with functional MRI (fMRI), functional near infra-red spectroscopy (fNIRS) is easy to handle, less expensive, and does not require a lying position. fNIRS is consequently more adapted for repeated acquisitions. Neurofeedback has already shown some promising results for neurological and psychiatric diseases. For mental states and emotion regulation, neurofeedback targeting the prefrontal cortex (PFC) has also shown promising outcomes. In this project, the investigators want to assess the effect of neurofeedback targeting the dorsolateral PFC (dlPFC) in a population of young adult women presenting emotional overeating. The investigators aim to improve the cognitive control and to reduce the episodes of emotional overeating in order to prevent the occurrence of subsequent pathologies.

The intervention effect will be characterized with: (i) fMRI in order to evaluate the effect on cognitive control (with resting state fMRI or rsMRI) and on the reward system; (II) questionaries directly and one month after intervention in order to assess the behavioral effect.

Besides an expected effect on emotional overeating, the investigators will evaluate whether an improvement of cognitive control can also promote positive effect on other behavioral traits that could lead to some pathologies such as food addiction.

As a prerequisite to this study on emotional overeating (study B), the investigators will firstly validate on healthy subjects (study A) a reward anticipation fMRI task, which will be further used in study A in order to characterized the effect of neurofeedback on the reward system.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hyperphagia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Study A

Validation of the reward system-related fMRI task, as determined by an increased activation on the brain reward structure (striatum) under the task.

Group Type OTHER

Neurofeedback with functional near infra-red spectroscopy

Intervention Type DEVICE

the neurofeedback protocol will last 15 minutes per session, and during each session, the volunteer will have to increase the brain activity of his/her dorsolateral prefrontal cortex using a visual gauge representing the "activity level" of his/her own dorsolateral prefrontal cortex. No specific instructions will be given to the volunteer so that he/she can develop his/her own internal strategy to increase this "activity level".

resting-state fMRI

Intervention Type DEVICE

characterize the brain function of volunteers by resting-state fMRI

Electro gastrogram

Intervention Type DEVICE

Volunteers will also be equipped with an MRI-compatible electro-gastrogram device to correlate gastric signals with brain activity during rsMRI acquisition.

Study B - Neurofeedback

The neurofeedback protocol will be the same during the 8 sessions constituting the protocol and taking place over a period of 4 weeks (2 neurofeedback sessions per week, the first and the last one in an MRI context). It will last 15 minutes per session, and during each session, the volunteer will have to increase the brain activity of his/her dlPFC using a visual gauge representing the "activity level" of his/her own dlPFC. No specific instructions will be given to the volunteer so that he/she can develop his/her own internal strategy to increase this "activity level".

Group Type EXPERIMENTAL

Neurofeedback with functional near infra-red spectroscopy

Intervention Type DEVICE

the neurofeedback protocol will last 15 minutes per session, and during each session, the volunteer will have to increase the brain activity of his/her dorsolateral prefrontal cortex using a visual gauge representing the "activity level" of his/her own dorsolateral prefrontal cortex. No specific instructions will be given to the volunteer so that he/she can develop his/her own internal strategy to increase this "activity level".

oral microbiota collection

Intervention Type OTHER

an examination and oral swab for oral microbiota analysis will be performed by a dentist

Questionnaires

Intervention Type OTHER

questionnaires for pre-intervention behavioral characterization

resting-state fMRI

Intervention Type DEVICE

characterize the brain function of volunteers by resting-state fMRI

Electro gastrogram

Intervention Type DEVICE

Volunteers will also be equipped with an MRI-compatible electro-gastrogram device to correlate gastric signals with brain activity during rsMRI acquisition.

Emotional Stroop task

Intervention Type BEHAVIORAL

an emotional Stroop task adapted to food and body image representation

Study B - Control

In the control group with neurofeedback sham, the participants will receive the same instruction but will be shown a random signal, the goal being that the control strategy the participant tries to implement is not correlated with the visual feedback provided by the gauge.

Group Type SHAM_COMPARATOR

Sham Neurofeedback

Intervention Type DEVICE

the participants will receive the same instruction but will be shown a random signal

oral microbiota collection

Intervention Type OTHER

an examination and oral swab for oral microbiota analysis will be performed by a dentist

Questionnaires

Intervention Type OTHER

questionnaires for pre-intervention behavioral characterization

resting-state fMRI

Intervention Type DEVICE

characterize the brain function of volunteers by resting-state fMRI

Electro gastrogram

Intervention Type DEVICE

Volunteers will also be equipped with an MRI-compatible electro-gastrogram device to correlate gastric signals with brain activity during rsMRI acquisition.

Emotional Stroop task

Intervention Type BEHAVIORAL

an emotional Stroop task adapted to food and body image representation

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Neurofeedback with functional near infra-red spectroscopy

the neurofeedback protocol will last 15 minutes per session, and during each session, the volunteer will have to increase the brain activity of his/her dorsolateral prefrontal cortex using a visual gauge representing the "activity level" of his/her own dorsolateral prefrontal cortex. No specific instructions will be given to the volunteer so that he/she can develop his/her own internal strategy to increase this "activity level".

Intervention Type DEVICE

Sham Neurofeedback

the participants will receive the same instruction but will be shown a random signal

Intervention Type DEVICE

oral microbiota collection

an examination and oral swab for oral microbiota analysis will be performed by a dentist

Intervention Type OTHER

Questionnaires

questionnaires for pre-intervention behavioral characterization

Intervention Type OTHER

resting-state fMRI

characterize the brain function of volunteers by resting-state fMRI

Intervention Type DEVICE

Electro gastrogram

Volunteers will also be equipped with an MRI-compatible electro-gastrogram device to correlate gastric signals with brain activity during rsMRI acquisition.

Intervention Type DEVICE

Emotional Stroop task

an emotional Stroop task adapted to food and body image representation

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Normal Body Mass Index (18.5-25),
* Right-handlers
* Affiliated to a social security scheme
* Having given a free, informed and written consent


* Normal BMI (18.5-25),
* Right-handlers
* Affiliated to a social security scheme
* Having given a free, informed and written consent
* Based on emotional overeating questionary : having emotional overeating episodes \> 6 days in a month for at least one negative emotion

Exclusion Criteria

Related to the study - Insufficient command of French

Related to Magnetic Resonance Imagine

* Implantable cardiac pacemaker or defibrillator;
* Neurosurgical clips;
* Cochlear implants;
* Neural or peripheral stimulator;
* Foreign orbital or brain metallic foreign bodies;
* Endoprostheses implanted for less than 4 weeks and osteosynthesis materials placed for less than 6 weeks;
* Claustrophobia. Related to near infra Red spectroscopy
* Hairs that do not allow proper near infra Red spectroscopy measurement upon ligh blockage

Study B

* Minimum age : 18 Years
* Maximum Age : 25 Years
* Sex : women


Related to the study

* Insufficient command of French
* Excessive consumption of alcohol or other psychoactive substances (determined on the basis of the Alcohol Use Disorders Identification Test questionnaires - excluded if score \> 12 and "Car, Relax, Alone, Forget, Friends, Trouble" questionnaire - excluded if score\> 1 " yes ")
* Eating disorders ("sick, control, one stone, fat, food" questionnaire \>2)
* Food addiction (Yale Food Addiction Score 2.0, score \>2
* With psychoactive treatment
* Digestive or gastric disorders

Related to magnetic resonance imaging

* Implantable cardiac pacemaker or defibrillator;
* Neurosurgical clips;
* Cochlear implants;
* Neural or peripheral stimulator;
* Foreign orbital or brain metallic foreign bodies;
* Endoprostheses implanted for less than 4 weeks and osteosynthesis materials placed for less than 6 weeks;
* Claustrophobia.

Related to near infraRed spectroscopy

\- Hairs that do not allow proper near infraRed spectroscopy measurement upon ligh blockage
Minimum Eligible Age

18 Years

Maximum Eligible Age

50 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement

OTHER

Sponsor Role collaborator

Rennes University Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Romain Moirand, MD

Role: PRINCIPAL_INVESTIGATOR

CHU Rennes

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Chu Rennes - Pontchaillou

Rennes, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Loïc JACOB

Role: CONTACT

0299282555

Nicolas COQUERY, PhD

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Romain Moirand, MD

Role: primary

Nicolas COQUERY

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2021-A02314-37

Identifier Type: OTHER

Identifier Source: secondary_id

35RC20_9849_Cemov

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Food and the Brain
NCT02743000 COMPLETED
Binge Eating Anxiety and Mood
NCT04242550 COMPLETED NA
Craving Network Neurofeedback
NCT06426693 RECRUITING NA